BEAT logo

BEAT HeartBeam Inc

$0.5806
$0.0736
(11.25%)
Today
86

Extremely Bullish Sentiment

How do you feel about BEAT?

Loading...

This is an ad slot. Start your free Edge trial and you won't see any ads for 30 days.

Ad free · Full sentiment data · Expanded watchers · Advanced search · No credit card required.

Advertisement|

vintage84
$BEAT omg 403 million shares traded today. If there’s continuation in volume we shall see $1+ this week, then the upgrades, then compliance met, then multi center trial, etc. so many things to move this up!
19
Tryitin
$BEAT Bull flag ABCD pattern, bullish with great FDA news this morning. Home device to detect heart attack is a BIG deal....Should consolidate and retest today's high!
6
1
FLArnot
$BEAT Those that keep crying dilution, the max potential dilution BEAT has is an additional 42.39 million shares for a total outstanding (possibility, not current) of 98.739 million shares. Their high over the last year was $3.44 (closing, $4.00 intraday), that equates to $1.40 a share fully diluted to match year high. And that high didn't have the FDA approval. SO I FULLY CALL BS on the dilution as a reason to be bearish. This puppy has lots of room to run!
12
topstockalerts
HeartBeam shares after the FDA granted Breakthrough Device Designation to its HeartBeam System, designed to help physicians assess potential heart-attack symptoms remotely, including in patients’ homes. The FDA granted the designation in just 30 days, ahead of its standard 60-day review period, signaling strong regulatory interest. The designation provides HeartBeam with prioritized FDA review and closer regulatory collaboration while potentially supporting accelerated Medicare coverage pathways. The company estimates a roughly $15 billion market for heart-attack assessment within a broader cardiac platform opportunity exceeding $40 billion. The designation was supported by data from the 134-patient ALIGN-ACS pilot study, with full results expected at the TCT conference later this month, providing a near-term catalyst. Shares reached an intraday high of $0.939 before paring gains, while the broader Nasdaq and S&P 500 rose 0.8% and 0.5%, respectively. $BEAT
11
Bossman123123
$BEAT nice little reversal there. This wouldnt get driven down too low following the news and interest. I think we can 5x from here comfortably. My money is staying in and i will enjoy the journey with the ups and downs along the way
11
vintage84
$BEAT FDA approved in less than 30 days. That is a significant piece in this. The standard review window is 60 days!! The volume is 370 mill already and nearly 7x the outstanding shares. That is insane. Flip all you want here under $1 but this is going to multi dollar land! 🍾🚀🍾🚀💰💰💰💰
1
7
vintage84
$BEAT today’s news, FDA responding within 30 days when they had 60 days to respond, and near 400M volume, should have taken this to above $1. I’m a bit shocked it didn’t get there. But still bullish long term. The next few months has now become very interesting.
9
GreenRagingBull88
$BEAT We might of reached the bottom!!! Good time to jump in, in my opinion!!!! NFA!!! Let’s get back to $.75+++!!!
7
Bearbull_Baggins
$BEAT "They have a $25 million ATM" WHO CARES. Look at the volume. That aint shit. Let them exhaust it in one day, in one hour! Look at this market cap and the accompanying news. Strong cash position from ATM = more leverage with partnership/buyout negotiations. Institutions and funds will gobble that ATM up. Day traders can cry, investors rejoice
2
3
Life_Coach
$BEAT Do I believe in karma. The Big book proves it. I believe you are the circle and everything comes back to you whether good or bad. We call it sowing and reaping. This stock is a life saver. Why not save a life What can I say about the heart.
7
FancyPants999
$BEAT penny flippers. They have a study coming end of month which should have all data on their ability to detect heart attacks at home. If it is successful, the fda approval that will be coming after will make the ip of this company worth 10 to 20x what it is currently. There is no approved diagnostic tool for at home heart attacks. Heartbeam would be the first ever.
7
Dizzy8
$BEAT Hmm, green within 2h. Hope someone listened and bought at 0.61 ish. I would not be surprised if we hit 1$ today. On the otherhand, I would be very surpised if we hit 0.5$. As such don't surprise me. 😁
7
Bossman123123
$BEAT matket manipulation to sweep up the SL's before a rise. Will catch us by surprise i think. I dont trade with stop losses on these stocks 😎
7
Dizzy8
$BEAT Still being shorted, quite a climb for the ctb. Might just go sideways for a while and abruptly jump when the shorts have depleted their oumph. Crazy numbers yesterday. Still think it will close green. But thats me.. LFG😎
6
jtsxlr
$BEAT I hate getting into a ticker with a 60% gap up and the RSI already over 77 but this news and device is worth it, I'm in for a starter and will add accordingly. I like it.
7
Rolltide2020
$BEAT TCT in San Diego in 4 weeks. When the Align-ACS results come out, it will be a total rerate on the stock. Same people who are patting themselves on the back for making 50 to 100% today will be kicking themselves for missing the banger that is coming.
7
Aboud_
$BEAT its very important to close above 0.60$ and would be bullish close between 0.62$-0.65$ range
5
Investor_Scale
$BEAT this is how Wall Street works, “they” are driving SP down and hope ST traders and penny traders will sell and move on. Algos are working overtime since yesterday I will hold. Period!
5
profitabletrader1234
$BEAT $15 Billion market size for heart diagnostics.... This is insane World first and FDA approval
6
TradeForLifeKing
$BEAT Buy and Hold, estimated 15B market value, I think big ginat biotech is buying them out guaranteed
6